Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BECTON DICKINSON & COBDX · Entity 2498 | EVP and President, EMEA | August 11, 2026 | August 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BECTON DICKINSON & CO
Report date August 11, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,856 |
Reported balance
After 2026-08-11 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-11 · Sale · Disposed 2,438 · Balance 14,856 F1: Securities sold were common stock acquired through the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). F2: Holdings reflect the addition of dividends the reporting person received as part of the equity adjustment made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. |
| Common StockSEC Table I · non-derivative | IndirectGSIP Trust | 1,779 |
Reported balance
Holding disclosure · report date 2026-08-11 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,779 F3: Represents shares of common stock held under the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). The information presented for the GSIP is as of August 3, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Securities sold were common stock acquired through the Becton, Dickinson and Company Global Share Investment Program (the "GSIP").
F2: Holdings reflect the addition of dividends the reporting person received as part of the equity adjustment made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp.
F3: Represents shares of common stock held under the Becton, Dickinson and Company Global Share Investment Program (the "GSIP"). The information presented for the GSIP is as of August 3, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 23, 2020 Filed Nov 24, 2020 21:52 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionStock Appreciation Rights · Derivative | 3,485 | $0.00 Strike: $76.64 | $0.00 |
DisclosureSEC source: 0001543407-20-000046 · edgar.xml · derivative · entry 5 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,485 shares Expires 2020-11-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 23, 2011. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:52 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 930 | $230.10 | $213,993.00 |
DisclosureSEC source: 0001543407-20-000046 · edgar.xml · nonDerivative · entry 3 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,994 F1 · balance_after: Includes 1,394 gain shares held by reporting person from the exercise of the stock appreciation right. Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:52 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Disposition to issuerCommon Stock | 1,161 | $230.10 | $267,146.10 |
DisclosureSEC source: 0001543407-20-000046 · edgar.xml · nonDerivative · entry 2 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,924 Read SEC document |
| November 23, 2020 Filed Nov 24, 2020 21:52 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionCommon Stock | 3,485 | $76.64 | $267,090.40 |
DisclosureSEC source: 0001543407-20-000046 · edgar.xml · nonDerivative · entry 1 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,085 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:08 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 4,630 | $0.00 Strike: $255.22 | $0.00 |
DisclosureSEC source: 0001543407-19-000061 · edgar.xml · derivative · entry 4 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,630 Underlying: Common Stock · 4,630 shares Expires 2029-11-26 F4 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2020. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:08 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 578 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000061 · edgar.xml · nonDerivative · entry 2 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,600 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2019 Filed Nov 27, 2019 19:08 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 931 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-19-000061 · edgar.xml · nonDerivative · entry 1 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,178 F1 · shares: Represents shares vesting under performance units granted on November 26, 2016. Read SEC document |
| August 08, 2019 Filed Aug 9, 2019 14:49 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionStock Appreciation Rights · Derivative | 2,463 | $0.00 Strike: $75.63 | $0.00 |
DisclosureSEC source: 0001543407-19-000041 · edgar.xml · derivative · entry 5 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,463 shares Expires 2019-11-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 24, 2010. Read SEC document |
| August 08, 2019 Filed Aug 9, 2019 14:49 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | SaleCommon Stock | 1,717 | $249.88 | $429,043.96 |
DisclosureSEC source: 0001543407-19-000041 · edgar.xml · nonDerivative · entry 3 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,247 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $249.83 through $249.88. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| August 08, 2019 Filed Aug 9, 2019 14:49 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Disposition to issuerCommon Stock | 746 | $249.88 | $186,410.48 |
DisclosureSEC source: 0001543407-19-000041 · edgar.xml · nonDerivative · entry 2 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,964 F1 · price: The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $249.83 through $249.88. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Read SEC document |
| August 08, 2019 Filed Aug 9, 2019 14:49 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Exercise / conversionCommon Stock | 2,463 | $75.63 | $186,276.69 |
DisclosureSEC source: 0001543407-19-000041 · edgar.xml · nonDerivative · entry 1 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,710 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 19:53 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 3,346 | $0.00 Strike: $242.10 | $0.00 |
DisclosureSEC source: 0001543407-18-000079 · edgar.xml · derivative · entry 5 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,346 Underlying: Common Stock · 3,346 shares Expires 2028-11-26 F5 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2019. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 19:53 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 368 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-18-000079 · edgar.xml · nonDerivative · entry 3 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,247 F3 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 19:53 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 703 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-18-000079 · edgar.xml · nonDerivative · entry 2 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,879 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 19:53 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 1,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-18-000079 · edgar.xml · nonDerivative · entry 1 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,582 F1 · shares: Represents shares vesting under performance units granted on November 26, 2015. Read SEC document |
| November 26, 2017 Filed Nov 28, 2017 13:43 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantStock Appreciation Rights · Derivative | 3,199 | $0.00 Strike: $226.28 | $0.00 |
DisclosureSEC source: 0001543407-17-000045 · edgar.xml · derivative · entry 5 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,199 Underlying: Common Stock · 3,199 shares Expires 2027-11-26 F5 · derivative.exercise_date: The stock appreciation rights vest in four annual installments beginning November 26, 2018. Read SEC document |
| November 26, 2017 Filed Nov 28, 2017 13:43 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 334 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-17-000045 · edgar.xml · nonDerivative · entry 3 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,406 F3 · shares: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Read SEC document |
| November 25, 2017 Filed Nov 28, 2017 13:43 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | Tax withholdingCommon Stock | 889 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-17-000045 · edgar.xml · nonDerivative · entry 2 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,072 F2 · shares: Represents shares withheld for payment of withholding taxes in connection with (A) vesting of the performance units referred to in footnote (1) and (B) the vesting of restricted stock units as previously reported on Table I. Read SEC document |
| November 25, 2017 Filed Nov 28, 2017 13:43 UTC | BECTON DICKINSON & CO BDX · Entity 2498 | GrantCommon Stock | 1,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001543407-17-000045 · edgar.xml · nonDerivative · entry 1 Goette Roland · CIK 0001708067 · EVP and President, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,961 F1 · shares: Represents shares vesting under performance units granted on November 25, 2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.